Antibody Drug Conjugates 2013 is a conference dedicated to new ideas to accelerate bispecifics, antibody-drug conjugates and empowered antibody therapies.
Antibody Drug Conjugates 2013 brings together representatives from:
- Academic and Research Institutes
- Biotech and Pharma Industry
- Antibody Discovery
- Antibody Development
- Formulation Development
- Antibody Engineering
- Monoclonal antibody operations
- Biologics
- Protein Engineering
- Immunoassay development
- Discovery Chemistry
- Translational Research
- Molecular Discovery Research
- Molecular Medicine
- Regulatory Affairs
- Molecular Biology and Chemistry
- Genomics
- Business Development
